Dr. AMJG nucleaire geneeskunde SRL
Dr. AMJG nucleaire geneeskunde reported total assets of 403,513 € at the end of the 2025 financial year (annual accounts filed with the NBB on 28 Jul 2026).
By total assets for 2025, Dr. AMJG nucleaire geneeskunde ranks in the top half of the 15,434 companies in its sector (NACE 8622) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Dr. AMJG nucleaire geneeskunde shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +295 % Total assets +205 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dr. AMJG nucleaire geneeskunde's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Jul 2026
- Year ended 31 Dec 2024filed on 30 Jul 2025
- Year ended 31 Dec 2023filed on 25 Jul 2024
Dr. AMJG nucleaire geneeskunde's financial analysis
- Solvency93.4%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dr. AMJG nucleaire geneeskunde
Dr. AMJG nucleaire geneeskunde's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0799.372.446
- VAT number
- No VAT activity declared to the CBE
- Peppol
- Registered · 0208:0799372446 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 09 Mar 2023
- Registered office
- 2160 Wommelgem
- Latest accounts
- 2025 · filed on 28 Jul 2026
- Activity
- Medical specialists activities (NACE 86220)
Dr. AMJG nucleaire geneeskunde (SRL) has been based in Wommelgem since 2023, active in: medical specialists activities. For 2025, it reports a net profit of 126,107 € and equity of 376,733 €; its revenue is not published. Its solvency stands at 93.4%, above the median of its sector (72.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Dr. AMJG nucleaire geneeskunde
Companies in the same business, of comparable size and area, outside its group.
- Lusyl Business and other management consultancy activities Deinze · balance sheet 403,435 €
- Palmen International Management Services Business and other management consultancy activities Brasschaat · balance sheet 403,932 €
- Fresma Rotselaar · balance sheet 403,647 €
- Archimedic Molenbeek-Saint-Jean · balance sheet 403,348 €
- Docteur Ingrid NEVEN Waremme · balance sheet 403,191 €
- Cabinet Medical B.Michel Mons · balance sheet 403,903 €
- Hardelingen Bilzen-Hoeselt · balance sheet 403,120 €
Frequently asked questions about Dr. AMJG nucleaire geneeskunde
What is the revenue of Dr. AMJG nucleaire geneeskunde?
Dr. AMJG nucleaire geneeskunde files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dr. AMJG nucleaire geneeskunde?
According to the Crossroads Bank for Enterprises, no VAT-liable activity is declared for Dr. AMJG nucleaire geneeskunde. If it is VAT-registered, its VAT number is its company number prefixed with BE: BE0799372446. Its company number (CBE) is 0799.372.446.
Where is the registered office of Dr. AMJG nucleaire geneeskunde?
According to the CBE register, the registered office of Dr. AMJG nucleaire geneeskunde is in 2160 Wommelgem.
What is the equity of Dr. AMJG nucleaire geneeskunde?
At the close of the 2025 financial year, the equity of Dr. AMJG nucleaire geneeskunde amounts to 376,733 €, a solvency of 93.4% of total assets.
Who manages Dr. AMJG nucleaire geneeskunde?
The register lists 1 active mandates at Dr. AMJG nucleaire geneeskunde. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Dr. AMJG nucleaire geneeskunde within its sector?
By total assets for 2025, Dr. AMJG nucleaire geneeskunde ranks in the top half of the 15,434 companies in its sector (NACE 8622) in Belgium that filed accounts for that financial year.
The full file of Dr. AMJG nucleaire geneeskunde
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →